Healthcare provider profile · identity verified

Lewin Go Chuachiaco, MD

Internal Medicine · DULUTH, GA · NPI 1134270721

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	590	180
Amlodipine Besylate	Amlodipine Besylate	451	127
Lisinopril	Lisinopril	276	88
Pantoprazole Sodium	Pantoprazole Sodium	266	98
Rosuvastatin Calcium	Rosuvastatin Calcium	237	73
Losartan Potassium	Losartan Potassium	220	66
Levothyroxine Sodium	Levothyroxine Sodium	218	66
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	208	37
Potassium Chloride	Potassium Chloride	205	60
Tamsulosin Hcl	Tamsulosin Hcl	189	59
Hydrochlorothiazide	Hydrochlorothiazide	172	53
Gabapentin	Gabapentin	170	60
Albuterol Sulfate Hfa	Albuterol Sulfate	157	76
Metformin Hcl Er	Metformin Hcl	157	47
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	145	42
Metformin Hcl	Metformin Hcl	142	39
Jardiance	Empagliflozin	138	34
Simvastatin	Simvastatin	134	39
Omeprazole	Omeprazole	131	44
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	128	14
Glipizide	Glipizide	127	41
Metoprolol Tartrate	Metoprolol Tartrate	113	34
Montelukast Sodium	Montelukast Sodium	110	34
Trazodone Hcl	Trazodone Hcl	103	35
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	101	28
Allopurinol	Allopurinol	97	30
Pradaxa	Dabigatran Etexilate Mesylate	95	26
Ibuprofen	Ibuprofen	86	38
Meloxicam	Meloxicam	86	35
Finasteride	Finasteride	84	26
Metoprolol Succinate	Metoprolol Succinate	83	31
Prednisone	Prednisone	83	58
Alendronate Sodium	Alendronate Sodium	82	29
Clopidogrel	Clopidogrel Bisulfate	77	26
Sertraline Hcl	Sertraline Hcl	77	28
Tramadol Hcl	Tramadol Hcl	77	24
Trospium Chloride	Trospium Chloride	77	28
Lovastatin	Lovastatin	73	20
Furosemide	Furosemide	71	35
Wixela Inhub	Fluticasone Propion/Salmeterol	68	18
Atenolol	Atenolol	66	23
Doxazosin Mesylate	Doxazosin Mesylate	64	18
Oxycodone Hcl	Oxycodone Hcl	61	suppressed
Mupirocin	Mupirocin	51	29
Buspirone Hcl	Buspirone Hcl	50	18
Carvedilol	Carvedilol	50	18
Memantine Hcl	Memantine Hcl	48	14
Mirtazapine	Mirtazapine	47	17
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	46	17
Ondansetron Odt	Ondansetron	46	19
Hydrocortisone	Hydrocortisone	41	18
Pravastatin Sodium	Pravastatin Sodium	41	12
Alvesco	Ciclesonide	39	15
Spironolactone	Spironolactone	39	11
Triamcinolone Acetonide	Triamcinolone Acetonide	37	22
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Acyclovir	Acyclovir	34	11
Nitroglycerin	Nitroglycerin	34	12
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Nystatin	Nystatin	32	17
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	32	13
Donepezil Hcl	Donepezil Hcl	30	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Azithromycin	Azithromycin	27	25
Cephalexin	Cephalexin	27	25
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	25	25
Diclofenac Sodium	Diclofenac Sodium	25	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	25	23
Humulin N	Insulin Nph Human Isophane	25	suppressed
Ketoconazole	Ketoconazole	25	11
Naproxen	Naproxen	25	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	21
Fenofibrate	Fenofibrate	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Amoxicillin	Amoxicillin	21	13
Humulin R	Insulin Regular, Human	21	suppressed
Ipratropium Bromide	Ipratropium Bromide	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	15
Fluconazole	Fluconazole	20	14
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	18	suppressed
Felodipine Er	Felodipine	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	17
Duloxetine Hcl	Duloxetine Hcl	16	suppressed
Labetalol Hcl	Labetalol Hcl	16	suppressed
Methylprednisolone	Methylprednisolone	16	15
Xarelto	Rivaroxaban	16	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	15	suppressed
Lactulose	Lactulose	15	suppressed
Metronidazole	Metronidazole	15	11
Pregabalin	Pregabalin	15	suppressed
Darifenacin Er	Darifenacin Hydrobromide	14	suppressed
Estradiol	Estradiol	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Clonidine Hcl Er	Clonidine Hcl	13	suppressed
Epinephrine	Epinephrine	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	13	suppressed
Torsemide	Torsemide	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Ssd	Silver Sulfadiazine	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Valsartan	Valsartan	12	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	11	11
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Colestipol Hcl	Colestipol Hcl	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error